Skeletal response to teriparatide in real-life setting: effects of age, baseline bone density and prior denosumab use.

Konings, Valerie; Laurent, Michaël R; Janssens, Sigrid; Dupont, Jolan; Gielen, Evelien; Dejaeger, Marian

Konings, Valerie; Laurent, Michaël R; Janssens, Sigrid; Dupont, Jolan; Gielen, Evelien; Dejaeger, Marian.

Afiliación

Konings V; Department of Geriatrics, University Hospitals Leuven, Leuven, Belgium.
Laurent MR; Department of Geriatrics, Imelda Hospital, Bonheiden, Belgium.
Janssens S; Centre for Metabolic Bone Diseases, University Hospitals Leuven, Leuven, Belgium.
Dupont J; Department of Public Health and Primary Care, Laboratory of Gerontology and Geriatrics, KULeuven, Leuven, Belgium.
Gielen E; Department of Geriatrics, University Hospitals Leuven, Leuven, Belgium.
Dejaeger M; Centre for Metabolic Bone Diseases, University Hospitals Leuven, Leuven, Belgium.

Acta Clin Belg ; 78(6): 446-451, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37466144

Palabras clave

bone mineral density; denosumab; osteoporosis; real-life setting; teriparatide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Acta Clin Belg Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google